Andrew Booth - Net Worth and Insider Trading
Andrew Booth Net Worth
The estimated net worth of Andrew Booth is at least $857,556 dollars as of 2024-12-11. Andrew Booth is the CFO of AbCellera Biologics Inc and owns about 283,959 shares of AbCellera Biologics Inc (ABCL) stock worth over $857,556. Details can be seen in Andrew Booth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Booth has not made any transactions after 2023-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Booth
Andrew Booth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Booth owns 1 companies in total, including AbCellera Biologics Inc (ABCL) .
Click here to see the complete history of Andrew Booth’s form 4 insider trades.
Insider Ownership Summary of Andrew Booth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABCL | AbCellera Biologics Inc | 2023-05-26 | Chief Financial Officer |
Andrew Booth Latest Holdings Summary
Andrew Booth currently owns a total of 1 stock. Andrew Booth owns 283,959 shares of AbCellera Biologics Inc (ABCL) as of May 26, 2023, with a value of $857,556.
Latest Holdings of Andrew Booth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABCL | AbCellera Biologics Inc | 2023-05-26 | 283,959 | 3.02 | 857,556 |
Holding Weightings of Andrew Booth
Andrew Booth Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Booth has made a total of 4 transactions in AbCellera Biologics Inc (ABCL) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in AbCellera Biologics Inc is the acquisition of 14,500 shares on May 26, 2023, which cost Andrew Booth around $99,325.
Insider Trading History of Andrew Booth
- 1
Andrew Booth Trading Performance
GuruFocus tracks the stock performance after each of Andrew Booth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Booth is 16.32%. GuruFocus also compares Andrew Booth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Booth within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Booth's insider trading performs compared to the benchmark.
Performance of Andrew Booth
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.24 | | | | | |
| Relative Return to S&P 500(%) | 5.06 | | | | | |
Andrew Booth Ownership Network
Andrew Booth Owned Company Details
What does AbCellera Biologics Inc do?
Who are the key executives at AbCellera Biologics Inc?
Andrew Booth is the Chief Financial Officer of AbCellera Biologics Inc. Other key executives at AbCellera Biologics Inc include 10 percent owner Thermopylae Holdings Ltd. , director & Chief Operating Officer Veronique Lecault , and director & 10 percent owner John Hamer .
AbCellera Biologics Inc (ABCL) Insider Trades Summary
Over the past 18 months, Andrew Booth made no insider transaction in AbCellera Biologics Inc (ABCL). Other recent insider transactions involving AbCellera Biologics Inc (ABCL) include a net purchase of 50,000 shares made by Michael R Hayden , a net purchase of 283,516 shares made by Thermopylae Holdings Ltd. , and a net purchase of 30,000 shares made by John S. Montalbano .
In summary, during the past 3 months, insiders sold 0 shares of AbCellera Biologics Inc (ABCL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AbCellera Biologics Inc (ABCL) were sold and 383,516 shares were bought by its insiders, resulting in a net purchase of 383,516 shares.
AbCellera Biologics Inc (ABCL)'s detailed insider trading history can be found in Insider Trading Tracker table.
AbCellera Biologics Inc Insider Transactions
Andrew Booth Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Booth. You might contact Andrew Booth via mailing address: C/o Abcellera Biologics Inc., 2215 Yukon Street, Vancouver A1 V5y 0a1.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
